Features
CAR T-Cell Therapy Brings New Hope to Cancer Patients at Stanford Health Care
CAR T-cell therapy offers a new treatment option for patients with certain blood cancers who did not response to other treatments.
COVID-19 Updates: COVID-19 Resources » Vaccine Update » Updated Visitor Policy » What We're Doing to Keep You Safe »
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Get the iPhone MyHealth app »
Get the Android MyHealth app »
The Stanford Blood and Marrow Transplant Program combines 25 years of treatment expertise, state-of-the-art research and comprehensive support services to provide the best possible outcomes. Offering treatment for malignant and non-malignant diseases, including lymphoma, myeloma, leukemia, myelodysplastic syndromes, and selected solid tumors, our program strives to integrate each patient into normal, everyday life.
Are you a patient or physician interested in CAR-T gene therapy? To make an appointment with one of our cancer specialists, call 650-498-6000.
The following is a list of diseases treated by the Stanford Blood and Marrow Transplant Program.
A type of blood cancer in which bone marrow makes too many granulocytes (a type of white blood cell that normally fights infection). The term "acute" means the disease progresses rapidly.
A cancer of the blood in which too many lymphocytes, a type of white blood cell which normally fights infection, are produced by the bone marrow and by organs of the lymph system.
A disease characterized by an abnormal build up of proteins (called amyloids) in various organs in the body.
A rare condition that occurs when the body stops producing enough new blood cells, causing fatigue and an increased risk of infections and uncontrolled bleeding.
A chronic form of cancer that starts in the blood-forming cells of the bone marrow and invades the blood and other parts of the body over time.
A type of blood cancer in which bone marrow and other lymphatic system organs slowly make too many lymphocytes (a type of white blood cell). The term "chronic" means the disease progresses more slowly.
A rare type of lymphatic system cancer which causes some lymphatic cells to abnormally reproduce, eventually creating tumors and making the body less able to fight infection.
An autoimmune disease in which the immune system attacks the body's cells and tissue, resulting in widespread, chronic inflammation and tissue damage.
A type of cancer that affects certain white blood cells and collects in the bone marrow and the outer layer of the bone.
A skin cancer characterized by patches, plaques, and tumors where cancerous cells have invaded the skin. It can also progress to internal organs over time.
A group of diseases that cause immature blood cells to accumulate in the bone marrow leading to a shortage of mature blood cells.
A rare skin cancer. While it’s slow-growing and seldom spreads to other parts of the body, it can grow into nearby fat and muscle and around adjacent nerves without proper treatment.
A type of cancer of the lymphatic system which can begin in almost any part of the body, causing cells to abnormally reproduce and tumors to eventually grow.
Cancerous (malignant) tumors of the connective tissues. Sarcoma is classified as bone or soft tissue sarcomas.
CAR T-cell therapy offers a new treatment option for patients with certain blood cancers who did not response to other treatments.
To commemorate the 30-year anniversary of blood and marrow transplantation at Stanford, the BMT program held a celebration for its more than 300 faculty, nurses and staff on Nov. 2, 2017.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Review the New Patient Packet for information about:
The initial evaluation process begins with a referral from your hematologist or oncologist to a Stanford Blood and Marrow Transplantation Program doctor. After this referral, the Stanford Blood and Marrow Transplant Program new patient coordinator will call you with an appointment date and time.
Bring completed forms found in the BMT New Patient Letter.
Please fax the Medical Record Release Form to your new patient coordinator. The medical release form is an authorization form for external facilities to release medical records to Stanford Health Care.
International Patients
Phone: +1 650-723-8561
Email: IMS@stanfordhealthcare.org
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8:30 a.m. – 5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
Email or fax a cancer referral form with supporting documentation to ReferralCenter@stanfordhealthcare.org or 650-320-9443.
To make an appointment with one of our cancer specialists, call 650-498-6000.